Portfolio News

Corbus Pharma (CRBP) Announces Issuance of Composition of Matter Patent Related to Lenabasum

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical stage drug development company with the industry’s leading pipeline focused on treating inflammatory and fibrotic diseases by targeting the endocannabinoid system, announced today that the U.S. Patent and Trademark Office (“USPTO”) issued Patent No. 10,154,986 to the Company which claims pharmaceutical compositions of lenabasum through 2034. Read more >>
Read more...

Pyramid Biosciences Announces Exclusive Global License of AstraZeneca TRK Program for Dermatology and Inflammatory Diseases

Pyramid Biosciences, Inc. (www.pyramidbio.com), a Boston-based biotechnology company developing new therapies focused on the modulation of cell surface receptors today announced it has entered into an exclusive, worldwide licensing agreement with AstraZeneca PLC for the development and commercialization rights to a novel Tropomyosin receptor kinase (TRK) modulator, PBI-100. Read more >>
Read more...

This 18-year-old company is somehow one of THE state’S hottest startups

One of the Boston area’s fastest-growing­ tech startups has been in business for 18 years. Aras, which makes software to help businesses manage the development of complex products, is an outlier in other ways, too. Its headquarters lies far from the glimmering new construction of the go-go technology scene in Boston and Cambridge, in a quiet Andover office park off of Interstate 495. Read more >>
Read more...